Nanoform Interim Report January – September 2021
Company Announcement Nanoform Finland Plc November 25, 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform Interim Report January – September 2021 The strong momentum continues: all near-term business targets for 2021 achieved, rapid customer project intake accelerating, commercial team in Europe expanded, more line capacity added, ISMS certificate received, and a new near-term business target introduced: “Biologics pilot line for GMP in 2022”. 7-9/2021 key financials: - Revenue came in at EUR 0.48 million, up 198 % compared with EUR 0.16 million in 7-9/2020.